Literature DB >> 28455242

The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.

Thibaut Barnoud1, M Lee Schmidt2, Howard Donninger3, Geoffrey J Clark4.   

Abstract

The Ras genes are the most frequently mutated oncogenes in human cancer. However, Ras biology is quite complex. While Ras promotes tumorigenesis by regulating numerous growth promoting pathways, activated Ras can paradoxically also lead to cell cycle arrest, death, and Oncogene-Induced Senescence (OIS). OIS is thought to be a critical pathway that serves to protect cells against aberrant Ras signaling. Multiple reports have highlighted the importance of the p53 and Rb tumor suppressors in Ras mediated OIS. However, until recently, the molecular mechanisms connecting Ras to these proteins remained unknown. The RASSF family of tumor suppressors has recently been identified as direct effectors of Ras. One of these members, NORE1A (RASSF5), may be the missing link between Ras-induced senescence and the regulation of p53 and Rb. This occurs both quantitatively, by promoting protein stability, as well as qualitatively via promoting critical pro-senescent post-translational modifications. Here we review the mechanisms by which NORE1A can activate OIS as a barrier against Ras-mediated transformation, and how this could lead to improved therapeutic strategies against cancers having lost NORE1A expression.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HIPK2; PP1A; RASSF; Ras; Retinoblastoma; p53

Mesh:

Substances:

Year:  2017        PMID: 28455242      PMCID: PMC5502528          DOI: 10.1016/j.canlet.2017.04.030

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  108 in total

1.  The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.

Authors:  Min Sup Song; Su Jung Song; So Yeon Kim; Hyun Jung Oh; Dae-Sik Lim
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

2.  The senescent side of tumor suppression.

Authors:  Manuel Collado; Manuel Serrano
Journal:  Cell Cycle       Date:  2005-12-18       Impact factor: 4.534

Review 3.  Drugging the undruggable RAS: Mission possible?

Authors:  Adrienne D Cox; Stephen W Fesik; Alec C Kimmelman; Ji Luo; Channing J Der
Journal:  Nat Rev Drug Discov       Date:  2014-10-17       Impact factor: 84.694

4.  Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions.

Authors:  Catherine Carrière; A Jesse Gore; Alixanna M Norris; Jason R Gunn; Alison L Young; Daniel S Longnecker; Murray Korc
Journal:  Gastroenterology       Date:  2011-05-27       Impact factor: 22.682

Review 5.  The RASSF1A tumor suppressor.

Authors:  Howard Donninger; Michele D Vos; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2007-09-15       Impact factor: 5.285

6.  RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells.

Authors:  Jessica J Mezzanotte; Victoria Hill; M Lee Schmidt; Thoraia Shinawi; Stella Tommasi; Dietmar Krex; Gabriele Schackert; Gerd P Pfeifer; Farida Latif; Geoffrey J Clark
Journal:  Epigenetics       Date:  2014-11       Impact factor: 4.528

Review 7.  Inside and out: the activities of senescence in cancer.

Authors:  Pedro A Pérez-Mancera; Andrew R J Young; Masashi Narita
Journal:  Nat Rev Cancer       Date:  2014-07-17       Impact factor: 60.716

8.  A comprehensive survey of Ras mutations in cancer.

Authors:  Ian A Prior; Paul D Lewis; Carla Mattos
Journal:  Cancer Res       Date:  2012-05-15       Impact factor: 12.701

9.  Cancer epigenetics: new therapies and new challenges.

Authors:  Eleftheria Hatzimichael; Tim Crook
Journal:  J Drug Deliv       Date:  2013-02-26

Review 10.  The Ras-association domain family (RASSF) members and their role in human tumourigenesis.

Authors:  Louise van der Weyden; David J Adams
Journal:  Biochim Biophys Acta       Date:  2007-07-04
View more
  3 in total

Review 1.  Pumping the brakes on RAS - negative regulators and death effectors of RAS.

Authors:  Desmond R Harrell Stewart; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2020-02-10       Impact factor: 5.285

Review 2.  Autoinhibition in Ras effectors Raf, PI3Kα, and RASSF5: a comprehensive review underscoring the challenges in pharmacological intervention.

Authors:  Ruth Nussinov; Mingzhen Zhang; Chung-Jung Tsai; Tsung-Jen Liao; David Fushman; Hyunbum Jang
Journal:  Biophys Rev       Date:  2018-09-29

Review 3.  Polyphenols as Caloric-Restriction Mimetics and Autophagy Inducers in Aging Research.

Authors:  Assylzhan Yessenkyzy; Timur Saliev; Marina Zhanaliyeva; Abdul-Razak Masoud; Bauyrzhan Umbayev; Shynggys Sergazy; Elena Krivykh; Alexander Gulyayev; Talgat Nurgozhin
Journal:  Nutrients       Date:  2020-05-08       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.